These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6291192)

  • 1. Inhibitory mechanism of dipyridamole on platelet aggregation ex vivo.
    Fukawa K; Saitoh K; Irino O; Ohkubo K; Hashimoto S
    Thromb Res; 1982 Aug; 27(3):333-40. PubMed ID: 6291192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.
    Liu Y; Cone J; Le SN; Fong M; Tao L; Shoaf SE; Bricmont P; Czerwiec FS; Kambayashi J; Yoshitake M; Sun B
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
    Simpson AW; Reeves ML; Rink TJ
    Biochem Pharmacol; 1988 Jun; 37(12):2315-20. PubMed ID: 2455518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole inhibits platelet aggregation in whole blood.
    Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
    Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation.
    Rickards KJ; Andrews MJ; Waterworth TH; Alexander GB; Cunningham FM
    J Vet Pharmacol Ther; 2003 Aug; 26(4):277-82. PubMed ID: 12887610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dipyridamole and its monoglucuronide derivative on adenosine uptake by human platelets and ADP-induced platelet aggregation.
    Subbarao K; Rucinski B; Niewiarowski S
    Biochem Pharmacol; 1977 May; 26(9):906-7. PubMed ID: 861060
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic platelet inhibitory effect of the phosphodiesterase inhibitor piroximone and iloprost.
    Buerke M; Dieterich HA; Meyer J; Darius H
    Agents Actions Suppl; 1992; 37():71-7. PubMed ID: 1378692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of trapidil and papaverine on thrombocyte aggregation and phosphodiesterase activity].
    Glusa E
    Farmakol Toksikol; 1986; 49(6):48-9. PubMed ID: 3028860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dipyridamole-like compound (R-E 244) on aggregation and cyclic AMP accumulation in human platelets.
    Söderbäck U; Sollevi A
    Thromb Res; 1991 Nov; 64(3):355-62. PubMed ID: 1666697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
    Sudo T; Ito H; Ozeki Y; Kimura Y
    Br J Pharmacol; 2001 Aug; 133(8):1396-404. PubMed ID: 11498527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA; Reimann S; Schrör K
    Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
    Dawicki DD; Agarwal KC; Parks RE
    Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function.
    Murray KJ; England PJ; Hallam TJ; Maguire J; Moores K; Reeves ML; Simpson AW; Rink TJ
    Br J Pharmacol; 1990 Mar; 99(3):612-6. PubMed ID: 2158847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function.
    Murray KJ; Eden RJ; Dolan JS; Grimsditch DC; Stutchbury CA; Patel B; Knowles A; Worby A; Lynham JA; Coates WJ
    Br J Pharmacol; 1992 Oct; 107(2):463-70. PubMed ID: 1422592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between milrinone and adenosine in the inhibition of human platelet response.
    Anfossi G; Massucco P; Piretto V; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Gen Pharmacol; 1996 Oct; 27(7):1149-54. PubMed ID: 8981060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro.
    Azuma H; Takashima Y; Ishikawa M; Yamakado T
    Jpn J Pharmacol; 1984 Feb; 34(2):159-70. PubMed ID: 6205194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
    Agarwal KC; Buckley RS; Parks RE
    Thromb Res; 1987 Jul; 47(2):191-200. PubMed ID: 2821650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
    Heptinstall S; Fox S; Crawford J; Hawkins M
    Thromb Res; 1986 Apr; 42(2):215-23. PubMed ID: 3715801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.